HomeStocks

MMJ

Director Trades

DateDirectorValue

Company News

Cannabis Access Clinics looks to aid Australian patient access to medical cannabis
Oct 28, 2020 • 12:06 PM
Hot Topics

Cannabis Access Clinics looks to aid Australian patient access to medical cannabis

The theory behind medical cannabis is that it has the potential to soothe many of today’s ailments, with illnesses such as epilepsy, multiple sclerosis (MS) and post-traumatic stress disorder (PTSD) all in the firing line to be remedied. The reality, however, is far less idealistic and must include aspects such as overall cost, patient qualification […]

MMJ announces timely recreational cannabis deal through Harvest One in Canada
Jul 13, 2018 • 9:45 AM
Biotechnology

MMJ announces timely recreational cannabis deal through Harvest One in Canada

MMJ (ASX: MMJ) has pleased its shareholders this morning by announcing that subsidiary cannabis company Harvest One had signed an MoU with the British Columbia Liquor Distribution Board (BC LDB) for the supply of recreational cannabis. Harvest One is to acquire PhytoTech Therapeutics from MMJ, subject to MMJ shareholder approval later this year. The company […]

MMJ collars first Australian medical cannabis investment in start-up Martha Jane Medical
May 31, 2018 • 10:06 AM
Biotechnology

MMJ collars first Australian medical cannabis investment in start-up Martha Jane Medical

MMJ (ASX: MMJ) has grown its exposure to the medical cannabis sector after securing its first Australian medical cannabis investment via a 12.6% stake for A$600,000 in privately-owned Australian medical cannabis research start-up Martha Jane Medical Ltd. Martha Jane Medical possesses an Australian medical cannabis research licence and is progressing other requisite medical cannabis licence […]

Australian pot stocks cultivating commercial progress in Canada
May 01, 2018 • 11:46 AM
Biotechnology

Australian pot stocks cultivating commercial progress in Canada

The onset of softening legislation towards cannabis in Canada and in other jurisdictions such as the US and Australia – both medicinally and recreationally – is providing a series of commercial opportunities for ASX-listed pot stock hopefuls such as Creso Pharma (ASX: CPH) and MMJ (ASX: MMJ). Both companies announced commercially encouraging news regarding their […]

MMJ PhytoTech puts money into securing tomorrow’s medical cannabis customers
Apr 10, 2018 • 9:23 PM
Biotechnology

MMJ PhytoTech puts money into securing tomorrow’s medical cannabis customers

As a sure sign of the softening stance towards cannabis in Australia, especially its medicinal branch, MMJ PhytoTech (ASX: MMJ) has pulled the trigger on investing A$1 million in exchange for a 16.7% ownership stake in Biologics Research Institute Australia Pty Ltd. Biologics Research Institute Australia is the owner of Cannabis Access, currently the leading […]

MMJ reports 250% planned cannabis flower production increase by 2019
Feb 07, 2018 • 5:02 PM
Biotechnology

MMJ reports 250% planned cannabis flower production increase by 2019

Pot stock investor MMJ PhytoTech (ASX: MMJ) reported its subsidiary Harvest One (TSX-V: HVST) plans to boost its cannabis flower production 250% by the end of 2019. MMJ holds more than 53 million shares in Harvest One, which, in turn, owns 100% of United Greeneries. According to MMJ, United Greeneries will expand its dried flower […]

MMJ PhytoTech reports early results in Phase 2 epilepsy trial
Jan 31, 2018 • 10:17 AM
Biotechnology

MMJ PhytoTech reports early results in Phase 2 epilepsy trial

The reintroduction of medical cannabis into treating illness and disease has received a boost, courtesy of clinical trials being conducted by MMJ PhytoTech (ASX: MMJ). In an update to shareholders, MMJ has published an update regarding the ongoing Phase 2 clinical trial of its Satipharm CBD capsules. From the results made available today, Satipharm capsules […]

MMJ secures stake in another Canadian pot company
Jan 30, 2018 • 3:10 PM
Biotechnology

MMJ secures stake in another Canadian pot company

MMJ PhytoTech (ASX: MMJ) has made another strategic investment in a Canadian pot company – this time, in Dosecann, which has a 45,000 square foot pharmaceutical production facility in the pipeline. In addition to the facility, Dosecann plans to obtain licensed dealer status by May to import and export cannabis, as well as gain licensed […]

Medicinal cannabis company MMJ PhytoTech receives conditional TSX-V listing approval
Dec 13, 2017 • 2:20 PM
Biotechnology

Medicinal cannabis company MMJ PhytoTech receives conditional TSX-V listing approval

MMJ PhytoTech Limited (ASX: MMJ) has advised that Harvest One Capital Inc. (NEX: WON.H) has received conditional approval from the TSX Venture Exchange (TSX-V) for the acquisition of MMJ’s wholly-owned subsidiaries United Greeneries Holdings Ltd and Satipharm AG. The resulting issuer, Harvest One Cannabis (TSX-V: HVST), has been approved as a Tier 1 Life Science Issuer, […]

First cannabis crop harvested at MMJ’s Duncan Facility
Dec 13, 2017 • 2:19 PM
Biotechnology

First cannabis crop harvested at MMJ’s Duncan Facility

MMJ PhytoTech Limited (ASX: MMJ) has advised the market that its wholly-owned subsidiary United Greeneries Holdings Ltd (UG) has successfully completed its first cannabis harvest at the Duncan Facility in Canada. UG’s first crop of the OG Kush strain has yielded approximately 60kg of dried cannabis buds, with the harvest passing strict internal quality control measures. […]

Company Videos